Yanina Grant-Huerta
Chief Accounting Officer; Chief Financial Officer · 4 filings · Latest: Aug 14, 2026
Atara Biotherapeutics, Inc.
ImageneBio, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ATRA | Yanina Grant-Huerta | Chief Accounting Officer | May 18, 2026 | Sale | $9.13 | 2,414 | $22.0K | 49,636 | |
ATRA | Grant-Huerta Yanina | — | May 18, 2026 | Proposed Sale | $10.48 | 2,754 | $28.9K | — | |
ATRA | Yanina Grant-Huerta | Chief Accounting Officer | Mar 2, 2026 | Sale | $5.08 | 2,104 | $10.7K | 31,750 | |
ATRA | Grant-Huerta Yanina | — | Mar 2, 2026 | Proposed Sale | $5.42 | 2,355 | $12.8K | — | |
ATRA | Grant-Huerta Yanina | — | Nov 17, 2025 | Proposed Sale | $13.76 | 2,069 | $28.5K | — | |
ATRA | Grant-Huerta Yanina | — | Aug 18, 2025 | Proposed Sale | $12.29 | 2,048 | $25.2K | — | |
ATRA | Grant-Huerta Yanina | — | May 16, 2025 | Proposed Sale | $7.61 | 2,350 | $17.9K | — |